LIXT
Lixte Biotechnology Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.21
−6.00%Leverage
- Debt / equity
- 0.13x
- Net debt / equity
- -0.28x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.14x
- Net debt / EBITDA
- 0.30x
Liquidity & coverage
- Current ratio
- 2.78x
- Quick ratio
- 2.78x
- Cash ratio
- 2.65x
- Interest coverage
- -700.53x
- EBITDA / interest
- -804.03x
- Working capital
- $2.2M
Cash & dividend
- FCF / debt
- -4.12x
- Cash flow / debt
- -4.10x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026